e-learning
resources
Vienna 2009
Sunday, 13.09.2009
COPD: basic science and clinical studies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Myeloperoxidase increased in plasma in patients with stable COPD
K. Andelid, P. Glader, B. Balder, A. Ekberg-Jansson, A. Lindén (Göteborg, Sweden)
Source:
Annual Congress 2009 - COPD: basic science and clinical studies
Session:
COPD: basic science and clinical studies
Session type:
Thematic Poster Session
Number:
916
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Andelid, P. Glader, B. Balder, A. Ekberg-Jansson, A. Lindén (Göteborg, Sweden). Myeloperoxidase increased in plasma in patients with stable COPD. Eur Respir J 2009; 34: Suppl. 53, 916
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Elevated serum inflammatory markers in patients with stable COPD
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009
Pulmonary rehabilitation causes a decrease in interleukin-8 and myeloperoxidase levels in sputum of patients with COPD
Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury
Year: 2009
Decreased levels of myeloperoxidase in induced sputum of COPD patients after oral glucocorticoids treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 404s
Year: 2002
Magnesium levels in erythrocytes and plasma in patients with exacerbated COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 429s
Year: 2001
Increased levels of hyaluronan in induced sputum from COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003
Elevated circulating MMP-9 is associated with increased exacerbation risk in COPD: results from SPIROMICS and COPDGene
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
MMP-9 expression and activity is incresed in the BAL of patients with acute exacerbation of COPD
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012
Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Overexpression of chitotriosidase and YKL-40 in serum and sputum in healthy smokers and patients with chronic obstructive pulmonary disease
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018
Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 248s
Year: 2001
Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD
Source: International Congress 2017 – COPD biomarkers
Year: 2017
Plasma levels of soluble RAGE are lower in COPD
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009
Il-6 levels in sera and induced sputum of COPD patients during exacerbations and stable period
Source: Eur Respir J 2005; 26: Suppl. 49, 284s
Year: 2005
Neutrophil activity assessed using a novel serological marker of human neutrophil elastase degraded calprotectin is elevated in patients with COPD or IPF
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021
Increased levels of osteopontin in sputum supernatant in patients with COPD
Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers
Year: 2012
Plasma leakage is elevated in COPD airways
Source: Eur Respir J 2005; 26: Suppl. 49, 441s
Year: 2005
Plasma acrolein level and myeloperoxidase gene polymorphism in COPD
Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Year: 2010
Can plasma arginase levels differantiate asthma and COPD?
Source: Eur Respir J 2007; 30: Suppl. 51, 372s
Year: 2007
Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018
Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept